Advance Care Planning
Recent research identified factors that increased the likelihood that clinicians would choose hospice care for themselves and examines how their preferences relate to the timing of end-of-life care discussions with patients.
Improved understanding of how to integrate the results into the treatment planning process is changing the course of treatment for some patients.
Cancer care entails a confusing labyrinth of screenings, tests, and treatments. This emerging role for nurses is becoming increasingly vital to achieve ideal patient outcomes.
Family-centered advance care planning left adolescent oncology patients significantly better informed than those who didn't have such sessions.
Early end-of-life talks are associated with less aggressive care and greater use of hospice services when patients do reach their final days.
Many persons who receive chemotherapy for incurable cancers may not understand that the treatment is unlikely to be curative.
A nurse-led palliative care intervention for persons newly diagnosed with metastatic cancer improved patients' emotional and mental quality of life.
The patient's daughter had been through the discharge process before. But she struggled with accepting her recurrent feelings. The nurse did, too.
Disease-specific advance care planning provides greater clarity about preferences, improving end-of-life care.
Prognosis is not good, but many patients still seek treatment, equating prolonged neurologic function with better quality of life.
Disease-specific advance care planning: Conversations emphasize patient preferences and provide claritySeptember 01, 2010
When planning for end-of-life care, disease-specific advance care planning delivers greater patient satisfaction and clarity about preferences.
Advance care planning can be applied in CPR decision-making at the end of life, but because medical technology advances mean increased length of palliative care and chronic illnesses, the decision of when to intervene has become more complex
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|